Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

IN BRIEF: Ondine Biomedical progresses with photodisinfection

5th Apr 2023 17:58

Ondine Biomedical Inc - Vancouver-based life sciences company innovating in the field of photodisinfection therapies - Concludes the first development phase of a new food-safe photodisinfection technology from Canada's meat packing industry. Ondine's photodisinfection is a patented technology using a photosensitizer - a non-antibiotic, light-activated solution - to destroy pathogens.

In December, Ondine was awarded nearly CAD735,000 - around GBP438,199 - to undertake this research which was, in part, funded by the Canadian government.

"The food-processing industry has a need for the development of technologies to reduce the incidence of food-borne pathogens including bacteria, fungi, viruses, and protozoa. Eradicating these invasive microbes will help protect the CAD9.4 billion (2021) Canadian meat export industry, as well enhance the lives and welfare of consumers by reducing the incidence of food-borne illnesses," the company explains.

Current stock price: 16.50 pence

12-month change: down 65%

By Heather Rydings, Alliance News senior economics reporter

Comments and questions to [email protected]

Copyright 2023 Alliance News Ltd. All Rights Reserved.


Related Shares:

Ondine Biomed
FTSE 100 Latest
Value8,809.74
Change53.53